Go to deals
Healthcare | Private Equity

BaltCap has sold InMedica to INVL Baltic Sea Growth Fund

BaltCap and a founder of InMedica have sold the company to INVL Baltic Sea Growth Fund. Financial details have not been disclosed.

InMedica is one of the largest private network of healthcare clinics in Lithuania. Employing more than 350 specialists, InMedica provides a vast range of medical services.

INVL Baltic Sea Growth Fund is a closed-end investment fund intended for professional investors and is focused on growth capital, buy-out, and buy-and-build investments, and will seek to form a diversified portfolio. INVL Baltic Sea Growth Capital Fund began its operation sin October 2018.

BaltCap is the leading independent private equity firm focusing on small and mid-market buyout and expansion capital investments in the Baltic States. Since 1995, BaltCap has managed several private equity and venture capital funds with a total capital of over US$295 million and has made more than 60 investments.

Oaklins' team in Lithuania advised the seller in this transaction.

Parties

Talk to the deal team

Martynas Visockas

Partner
Vilnius, Lithuania
Oaklins Baltics

Marius Binkevičius

Partner
Vilnius, Lithuania
Oaklins Baltics

Related deals

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Food & Beverage

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Armira has signed an agreement to acquire a majority stake in Viabus
Private Equity | Consumer & Retail

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Learn more